Summer School in Public Health Policy, Economics and Management

Transcription

1 From 25 to 30 August 2014 Lugano (Ticino, Switzerland) Facoltà di scienze economiche Istituto di Economia Politica IdEP

2 PREAMBLE Once again, Lugano is welcoming the SSPH+, jointly organized by SSPH+, the Institute of (IdEP) of the University of Lugano and the Swiss Tropical and Public Health Institute (Swiss TPH) in Basel. The is again expected to bring a highly international and interdisciplinary audience, interested not only in learning but in the professional exchange and the sharing of expertise, questions, and challenges. Building on last year s success, the 2014 program provides the opportunity to choose 6-day and 3-day courses. The daily plenaries will cover topics of broad relevance and interest to public health researchers and professionals. More than students have taken course in our summer school since it was offered for the first time in Whereas the first year students came mostly from Switzerland, the courses have seen a steady increase in students from Eastern, Central, and Western Europe thanks to generous scholarships of the Swiss Agency for Development and Cooperation (SDC). It will now be the fifth year where SSPH+ will welcome students from Africa and Asia too, thus, enriching s and exchanges with the expertise from regions with very different public health situations, challenges and opportunities. This can be exemplified in relation to a theme of a plenary session this year, namely the issue of big data. In contrast to most European countries, many regions in Africa and Asia have a long-standing experience in the collection of very big population based data. Through its approximately 50 health and demographic surveillance systems (HDSS) in Africa, Asia and Oceania, the INDEPTH network is capable of producing and analyzing very big and extremely dense longitudinal data. Every year, in each of some 50 sites across 20 countries and 3 continents, standard information of high public health relevance is collected from tens of thousands of people, who are visited up to four times per year.. Data are not only used to describe the lives of people in those low- and middle-income countries, but for research on the impact of development policies and programs on those lives. Some surveys have been on going for more than three decades providing rich data from poor populations. In contrast, Switzerland has rich people but poor data. Big population based data remain first of all the vision of a circle of public health experts who have taken up the mission to fight for Swiss funds and infrastructures that will provide the platform to health scientists and policy makers to monitor health and its determinants. Rich data are a fundamental basis on which to inform the development of scientific innovation and to apply it in policies and action, which in turn needs evaluation of its impact on public health and economy. May the again strengthen our visions and expertise to contribute to public health! Prof. Nino Künzli, MD PhD, Deputy Director of the Swiss Tropical and Public Health Institute Basel (Swiss TPH) and Professor of Social and Preventive Medicine of University Basel, Basel Switzerland 2

3 INTRODUCTION The Foundation Swiss School of Public Healthplus (SSPH+), the Institute of (IdEP) of the Università della Svizzera italiana and the Swiss Tropical and Public Health Institute (Swiss TPH) organize the in Public Health Policy,. Courses cater to professionals and managers of health administrations, hospitals and other services worldwide, health sector facilities, policy-makers and any student registered for one of the continuous education programs coordinated and supported by the SSPH+. The is an opportunity to meet new colleagues and peers, exchange knowledge, build networks, and share insights. The emphasis will be on participative approaches, complemented by formal teaching. This year s edition offers 5 courses distributed over 6 days and 6 short courses (3 days). Hence, each participant can attend 1 course of 6 days or 2 courses of 3 days. courses are recognized in the ECTS framework and count toward SSPH+ degree programmes. Each 6-day course is assigned a credit value of 2 ECTS and each 3-day course is assigned 1 ECTS. Those who actively participate and pass the final assessment are awarded a certificate of success. A certificate of attendance will be issued to any registered student who has regularly attended lectures and seminars. 3

4 COURSES OF THE MAIN PROGRAMME 6-day Courses (25-30 August 2014) COURSE N PAGE COURSE Course 1. page 9 Public Mental Health: Evaluations of Programmes and Policies Teachers: Prof. Emiliano Albanese, Prof. Martin Knapp Course 2. page 12 Governance of Comprehensive Health Networks Based on a Population Approach Teachers: Prof. Denis Roy, Prof. Fred Paccaud, Prof. Merita Berisha Course 3. page 15 mhealth: Mobile Communication for Public Health Teacher: Prof. Suzanne Suggs Course 4. page 18 Methodology and Practical Application of Economic Evaluation and HTA in Health Care Teachers: Dr. Urs Brügger, Prof. Mike Drummond, Marco Barbieri Course 5. page 22 Leadership and Communication Teacher: Prof. François Lagarde 3-day Short Courses (25-27 August 2014) Course 6. page 25 Health Financing Policies, Health System Performance and Obstacles to Universal Health Coverage Teachers: David B. Evans, Fabrizio Tediosi Course 7a. page 28 Incentives for Better Health Teachers: Prof. Iris Bohnet, Prof. Prof. Nikola Biller-Andorno, Dr. Divya Srivastava Course 8a. page 30 Rationales in Public Health Decisions How to Handle Research Information to Improve Decision-making Teachers: Dr. André Prost, Dr. Roberto Grilli 3-day Short Courses (28-30 August 2014) Course 7b. page 33 Conflicts of Interest and Corruption from a Health Systems Perspective Teachers: Prof. Marc Rodwin, Prof. Olivier Guillod, Prof. David Klemperer, Prof. Nikola Biller-Andorno and Dr. Judith Richter Course 8b. page 35 Bridging the Gap between Evidence and Policy Making Teacher: Prof. Andrew Street Course 9. page 35 Non-communicable Disease Control: Public Health and Health Care Approaches Teacher: Dr. Kaspar Wyss, Prof. Pascal Bovet Courses 7a and 7b are funded by the Swiss University Conference. They are autonomous and complementary. We encourage participants interested in the topic to register for both courses. 4

5 PLENARY SESSIONS 2014 From 25 to 30 agosto 2014 DATE TIME Big Data in Public Health Research: Will it Kill Epidemiology? Thick Data in Public Health Research: Epidemiology remains alive Global Health Issues Chair: Charlotte Braun-Fahrländer (Director SSPH+ and Professor, Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute) Discussants: Antoine Flahault (Director of the Institute of Global Health, University of Geneva) and Nino Künzli (Deputy Director Swiss Tropical and Public Health Institute) Chair: Axel Hoffmann (Head of Teaching and Training Unit, Swiss Tropical and Public Health Institute) Discussants: André Prost (Former Director, Department of Relations with Governments, WHO, Geneva, CH) and Marcel Tanner (Director, Swiss Tropical and Public Health Public Health Consequences of Economic Crises and Austerity Policies Chair: Fabrizio Tediosi (Research Group Leader, Health Systems Research and Dynamical Modelling Unit, Swiss Tropical and Public Health Institute, Basel, CH) Discussants: David Evans (Director, Health Systems Governance and Financing Department, World Health Organization, Geneva, CH) and Fabrizio Mazzonna (Assistant Professor, Università della Svizzera Italiana) Conflicts of Interests and Corruption Chair: Olivier Guillod (Director of the Institute of Health Law, University of Neuchâtel) Discussants: Marc Rodwin (Professor of Law at Suffolk University Law School, Boston and Edmond J. Safra Center, Harvard University, USA) and Marco Bobbio (former chief of cardiology, Santa Croce hospital of Cuneo, Italy) Too fast, too furious? Controversies of the global health movement Chair: Luca Crivelli ( Scientific Director, Vice-director SSPH+ and Professor, Università della Svizzera italiana) Discussants: Emiliano Albanese (Professor of Public Mental Health University of Geneva, and HUG, CH), Martin Knapp (Professor of Social Policy, London School of and Professor of Health, King s College London, UK) and Meichun Mohler-Kuo (Head of the Mental Health Sector, Institute of Social and Preventive Medicine, University of Zuerich) The plenary sessions are free of charge and open to the general public. For updates on this program please visit the website. 5

6 PRACTICAL INFORMATION VENUE All lectures and seminars are held at the campus of the Università della Svizzera italiana in Lugano (Switzerland). Address: Università della Svizzera italiana Via G. Buffi 13 CH-6900 Lugano (Switzerland) Phone Fax website The Lugano region is well known for the beauty of its landscape, lake, mountains and Mediterranean vegetation. For further information please visit and ACCOMMODATION Participants are expected to book their own hotel rooms. Lugano offers a wide selection of hotels and other residential accommodation (for details please visit and LANGUAGES Courses are taught in English. An excellent knowledge of the language is required. No translation is provided. Università della Svizzera italiana Facoltà di scienze economiche Center for Economic and Political Research on Aging CEPRA website: website: website: 6

7 GENERAL COURSE INFORMATION Courses are intended for professionals and managers operating in health administration, hospitals and other services and facilities within the health sector; they are also open to students registered for one of the continuous education programmes coordinated and supported by SSPH+. The program runs from 25 to 30 August The number of participants is limited to a maximum of 25 students per course. ECTS, CERTIFICATE OF SUCCESS Each 6-day course is assigned a credit value of 2 ECTS. Each short course of 3 days is assigned a credit value of 1 ECTS. Those who participate actively and pass the final assessment are awarded a certificate of success. A certificate of attendance will be issued to any registered student who has regularly attended lectures and seminars. The s ECTS have so far been recognised by the following SSPH+ programmes: MAS Arbeit + Gesundheit / Santé au Travail (ETH Zurich, Universities of Lausanne and Zurich) MAS en santé publique (University of Geneva) MAS en économie sciences et organization de la santé (Mas-Santé, University of Lausanne) Master of Public Health (Universities of Basel, Bern and Zurich) MAS in Versicherungsmedizin (University of Basel) Net-MEGS, MAS in economia e gestione sanitaria e sociosanitaria (University of Lugano) MAS en droit de la santé (University of Neuchâtel) Master of Business Administration in International Health Management (Swiss TPH) Master in International Health (Swiss TPH) COURSE FEES Fees cover tuition, all teaching materials, lunches and coffee breaks at the university restaurant (from Monday to Saturday). Travel, accommodation and dinners are not included. 6-day courses: Regular participants CHF Students enrolled in SSPH+ programs CHF 3-day courses: Regular participants 800 CHF Students enrolled in SSPH+ programs 650 CHF Participants who choose to register for 2 of the 3-day courses will benefit from a discount of 100 CHF. The courses of the are acknowledged by the SIWF (Schweizerisches Institut für ärztliche Weiterund Fortbildung) and are awarded 7 credits by the FMH (Swiss Medical Association) per day, up to of 25 FMH credits for the full week curriculum. MEALS The University restaurant serves excellent lunches (international cuisine) from Monday to Saturday. The does not arrange evening meals. Good restaurants can be found locally. 7

8 REGISTRATION Please complete the online registration form, which can be downloaded at: The closing date for registration is 15 July The number of participants is limited and priority will be given to those who register first. Participants will receive a confirmation of admission. Registration is valid upon receipt of the registration form and payment of the full registration fees. The balance must be settled by 15 July 2014 at the latest. Participants will receive the necessary preparatory documentation a few weeks before the beginning of the course. MEANS OF PAYMENT & CANCELLATION By bank transfer to: UBS SA CH-6900 Lugano Account no.: Y Code SWIFT/BIC: UBSWCHZH69A IBAN Code: CH Y Reference: and your name. By postal transfer to: La Posta CH-6900 Lugano Current postal account number: In favour of the account: Y Reference: and your name. Bank costs are chargeable to the participants. Full refund is guaranteed for cancellations received by 15 July Fees will not be reimbursed after this date. 8

9 COURSE 1 (6 days) Public Mental Health: Evaluations of Programmes and Policies Prof. Emiliano Albanese Prof. Martin Knapp CONTENT OF THE COURSE The first part of the course will identify the main policy issues in the mental health field, and discuss their implications for evaluation. The course will then set out the aims of and broad approaches to the evaluation of mental health programs, focusing specifically on economic approaches to evaluation and mental health policy and practice. Areas to be covered in the second part of the course include research methods in mental health and psychiatric epidemiology, fundamentals in public mental health (concepts; impact and interventions), the design of mental health policy, plans and programs as well as the organization of mental health systems. OBJECTIVES Prof. Albanese: To provide an introduction to population-based research methods on mental health and psychiatric disorders To provide an overview on public mental health concepts and principles in the context of global mental health To enable participants to critically evaluate the existing evidence relevant to public mental health policy, plans and programs and systems. Prof. Knapp: To describe the most important themes in national and local policies aimed at addressing mental health needs To introduce evaluation in the context of mental health policies and programmes, and economic evaluation in particular To describe how economic evaluations might be conducted in mental health contexts, with illustrations from across a range of areas To enable participants on the course to understand the core principles, strengths and weaknesses of economic evaluations in mental health contexts PREREQUISITES No prerequisite, but the course will mostly benefit individuals working in the public health sector, health economists, health professionals, policy makers, environmental professionals and others community leaders. PEDAGOGICAL METHOD Lectures, team work, practical sessions and group inherent the Course main subjects and participants own areas and topics of interest. ASSESSMENT PROCEDURE Written examination on Saturday August 30th. Optional Transfer of Knowledge Activity An optional assessment will be offered to interested participants only, with the goal of favouring transfer of knowledge of the Course contents to real life needs and situations. Detailed instructions will be provided on how to complete an essay on a topic of choice in public mental health, closely related to participants own areas of study or work. Essays will be due by the end of September 2014, and will be marked and returned with specific feedback and comments by the end of

10 COURSE 1 (6 days) COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday Psychiatric Epidemiology I Basic concepts in Epidemiology, and Measurements in Psychiatric epidemiology Lecture / group Practical / Monday Psychiatric Epidemiology II Scientific principles; Study Designs; Critical Appraisal and Interpretation of Findings Lecture/ group Practical/ group work Tuesday Public Mental Health Definitions and Concepts Key Points Issues in Public Mental Health Burden of Mental Disorders Lecture / group Practical / Tuesday Mental Health Policy, Plans & Programs Concepts Development and Implementation Steps Lecture / group Practical / Wednesday Organization of Mental Health Services Mental health systems: History; mhgap; guiding principles to reform health systems Lecture / group Group work Wednesday Recap, Q&A and Practical Activities / Discussion Thursday Mental health policy and evaluation: introduction Mental health needs, treatment, outcomes. Conceptual framework for analysing policy and framing evaluation. Lecture Group Thursday Mental health policy Dominant themes in policy internationally. How mental health policies are shaped: key influences. Introduction to the role of evaluation. Lecture Group Practical / Friday Evaluation of policy and programmes Approaches to evaluation of programmes and policies. Evaluation challenges in the mental health field. Introduction to economic evaluation in policy contexts Lecture Group Friday Economic evaluation I Why is economic evaluation needed? The core principles of economic evaluation Lecture Group Saturday Economic evaluation II Examples of economic evaluation and their influences on mental health policies and practices Lecture Group Practical / Saturday Economic evaluation III Further examples of economic evaluation and their influences. Written examination (covering the whole course) Lecture Group 10

11 COURSE 1 (6 days) CURRICULUM VITAE Prof. Emiliano Albanese Emiliano Albanese is a public health physician and epidemiologist. He is SSPH+ assistant professor of public mental health at the University of Geneva, and head of the new-born division of Public Mental Health of the Institute of Global Mental Health, Geneva School of Medicine. He is actively involved in numerous population-based studies, and he is particularly interested in the life course determinants of aging, cognitive decline and dementia. Emiliano has a joint appointment as clinical senior lecturer at the Institute of Psychiatry, King s College London; he is a study coordinator of the 10/66 research network on mental health, aging and dementia in low and middle-income countries, and is a member of the Global Observatory for Ageing and Dementia Care at King s, and of the Centre for Global Mental Health, and Gulbenkian Global Mental Health Platform (Université NOVA de Lisbonne). His teaching activities include master programs in Switzerland (Master en Sante Publique, Geneva), and the UK (MSc in Global Mental Health, LSHTM and KCL), and certificate of advanced studies (CAS) in Santé Publique (Lausanne) and Sante Mentale Publique (Geneva). In 2007 he co-authored, with Prof. Martin Knapp, the UK dementia report; in 2009 the World Alzheimer Report, and in 2014 the Nutrition and Dementia report. He is responsible of the area of Dementia of the WHO Collaborating center of the Department of Psychiatry of the Univesity of Geneva, and he collaborates with the Department of Mental Health and Substance Abuse of the World Health Organization for the revision and update of the WHO Mental Health Gap Action Plan (mhgap) clinical guidelines for dementia care by non-specialists in LMIC. Prof. Martin Knapp Martin Knapp is a researcher in the areas of health and social care policy and practice. He has been Professor of Social Policy and Director of the Personal Social Services Research Unit at the London School of and Political Science (LSE) since Since 2009, Martin has also been Director of the School for Social Care Research funded by the National Institute of Health Research. Until early 2014 he was also Professor of Health at the Institute of Psychiatry, King s College London, having established the Centre for the of Mental Health there in Martin s research emphases in recent years have primarily been child and adult mental health, dementia, autism and long-term social care, with much of his work having and economic focus. He has published his research widely, including in more than 450 peer-review articles and 15 books. His work has fed through to have many impacts on policy and practice s in the mental health and long-term care areas, both in the UK and elsewhere. Martin was recently appointed to the World Dementia Council. 11

12 COURSE 2 (6 days) Governance of Comprehensive Health Networks Based on a Population Approach Prof. Denis Roy Prof. Fred Paccaud Prof. Merita Berisha CONTENT OF THE COURSE Health systems: goals and context Complexity and networks in health Health network management Mandate, vision of the health network, population-based accountability and the triple aim Population oriented continuums of intervention Performance, knowledge and action within the health network Microsystems, mesosystems, macrosystem Health system governance Apparatus and functions, centralization and decentralization, supporting the local level using health policies to orient the system accountability, equity and respect of social values Towards health systems comprised of population-accountable networks an comprehensive model for effective health systems the health network s integrator role the potentiator role of system governance Conclusions OBJECTIVES By the end of this course, participants will be able to: understand how demographic, epidemiological and health transitions create the challenges currently facing complex health systems; describe why and how health networks may contribute to successfully addressing these challenges in a context of complexity; identify key management strategies useful in managing high performance health organisations and networks; understand how to may be mobilize and adapt governance levers in order to guide and support performance improvement; acquire a comprehensive view of the dynamics of complex health systems and of the strategies pertinent for their management and governance. PREREQUISITES Formal training in health or management disciplines; research and field experience may help participants to fully benefit from the course. PEDAGOGICAL METHOD Lectures, workshop s of examples and topical cases. Personal readings. Sharing of experiences among participants. ASSESSMENT PROCEDURE Short essay on a relevant, student- identified, topical area. 12

13 COURSE 2 (6 days) DETAILED COURSE CONTENT AND STRUCTURE Day Content Other teaching methods 1 Introduction and presentations Health systems: context and goals (1) demographic, epidemiological and health transitions objectives and components of the health system the challenge of adapting health systems The emergence of networks and complexity in health systems (2.1) The dynamics of health networks (2.5.3) The mandate of population-accountable health networks (3.1) 2 The health network in action: meeting the needs of a population (3.2) Designing health networks (2.5.4) The value of information in health networks (3.6) Health network performance (3.3) 3 Health as a complex adaptive system (2.2) Knowledge in action within the health network (3.4) Microsystems - Part 1 (3.5) 4 Managing health networks (3.5) Microsystems - part 2 Mesosystems The macrosystem 5 Health system governance (4) the governance apparatus governance functions 6 A health system comprised of populationaccountable networks (5) Synthesis and conclusion Individual reflection The challenges of achieving the triple aim of health networks with respect to a population familiar to the participant Plenary and feedback Small shop Assessing the needs of a population and setting priorities Determining key interventions of service continuums required to address priorities and identifying the actors involved. Plenary Small shop Analysing health system topics within a complexity framework Personal reflection and short essay Identifying simple, complicated and complex microsystems that are necessary to respond to a priority health issue in your professional context Individual reflection and plenary Defining improvement projects in one s professional context Discussion of the Quebec health network model Group and analysis Mesosystem management, the integrator role and macrosystem management in different health systems. Large shop Governance functions in health systems Fostering innovation: a case study and Group Take-home ideas from the course 13

14 COURSE 2 (6 days) CURRICULUM VITAE Denis A. Roy (MD, MPH, MSc, FRCPC) is currently Vice-president, Scientific Affairs at the Institut national de santé publique du Québec. Dr. Roy holds an MD from Laval University. In addition, he earned a Master of Public Health at the University of California, Berkeley, and a Master of Science at McGill University. A fellow of the Royal College of Physicians, he has been honored with numerous awards, including the Commonwealth Fund Harkness Associate Award and an Excellence Award by the Quebec Association of Community Health Physicians. Furthermore, he is the only Canadian to have twice received the Canadian Foundation for Health Services Research Award, which he obtained due to his outstanding work in Montreal and Monteregie. Dr. Roy is an international member of Conseil Scientifique III de l Institut National de Prévention et d éducation pour la Santé and president of Bureau de Direction de L Initiative Sur le Partage des Connaissances et le Développement des Competences, a broad-based capacity building initiative aimed at health system improvement in Quebec. Dr. Roy is associate professor at the Social and Preventive Medicine Department, University of Montreal, and a research associate at Charles-LeMoyne Hospital Research centre, affiliated with the Community Health Department, University of Sherbrooke. He is involved in post-graduate training programmes in community medicine and allied public health disciplines. Merita Berisha is graduate of Medical Faculty Prishtina University (MFPU). She holds Master degree in Public Health & Epidemiology. She was selected teaching assistant at the MFPU and Specialized in Social Medicine/Public Health at the National Institute of Public Health of Kosova. After completing the doctoral program at MFPU in 2001 she was appointed Prof.Ass and later Prof.Associate for Social Medicine and Health Statistics within undergraduate and postgraduate medical studies. In 2006 she was host professor for course Health Promotion and Education in International Prishtina Summer University. After that during the Master program for Health Managment, Tempus program, jointly with Medical University of Vienna, she led courses Health Care Strategies and Health Care Systems, and Biostatistics. She provides technical assistance to the Kosovo Government and international agencies in the area of health strategy, health information systems, health promotion, teaching methodologies and is involved in coordination of studies and researches. Besides Medical Faculty, she works at the National Institute of Public Helth of Kosova, Department of Social Medicine as a Chief of Observatory for mother, child and youth health. Recenlty she is nominated Acting Vice-Rector for quality and academic development at the University of Prishtina. 14

15 COURSE 3 (6 days) mhealth: Mobile Communication for Public Health Prof. Suzanne Suggs CONTENT OF THE COURSE The purpose of this course is to explore, analyze and examine mobile health (m-health) technologies and strategies used for public health communication purposes. Specifically, the course focuses on the use of m-health in promoting, facilitating, changing and maintaining health behaviors. m-health will be discussed and examined in Emphasis is placed on the planning and development process in terms of when and why to use m-health, how to develop m-health applications, and evaluation of m-health projects. This is not a technical course for programmers, but is a course for public workers and researchers. OBJECTIVES By the end of the course, the student will: understand the theoretical and practical relevance of m-health be familiar with the concepts, methods and applications of m-health technologies for public health purposes; understand research and planning steps needed when designing m-health applications; be able to design an m-health project; be able to identify and discuss important m-health programs, funding sources, alliances, and outcomes associated with m-health. PREREQUISITES None. PEDAGOGICAL METHOD The course will consist of interactive lessons, lectures and experiential learning activities. ASSESSMENT PROCEDURE Over the course of the six-day intensive class, students will demonstrate obtainment of learning objectives through class s and the final session. The final session will culminate in a presentation that demonstrates lessons learned. 15

16 COURSE 3 (6 days) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday What is m-health: Uses, communication, policy, economics Lecture and Monday m-health Case Studies Lecture and Tuesday Getting to know the problem and potential solutions Lecture and Tuesday Health behavior Lecture,, and Wednesday Designing m-health projects Lecture,, and Wednesday Persuasive communication Lecture,, and Thursday Management and policy implications of m-health communication Lecture,, and Thursday Group work on projects Group work Friday Implementing m-health projects Lecture,, and Friday Implementing m- health projects Group work Saturday M-health. Lessons Learned and implications for the future Discussion Saturday M-health. Lessons Learned and implications for the future Discussion 16

17 COURSE 3 (6 days) CURRICULUM VITAE L. Suzanne Suggs, PhD, MS, BBA, CHES is a Senior Assistant Professor of Social Marketing and Director of the BeCHANGE Research Group, Institute for Public Communication, Faculty of Communication Sciences at Università della Svizzera italiana (USI). Her principal research examines the use of social marketing, communication technologies, and messaging strategies to facilitate health behavior change, and to improve health outcomes. Prior to joining the faculty in Lugano (August 2007), she was an Assistant Professor in the Graduate Program in Health Communication, Department of Marketing Communication at Emerson College and Adjunct Assistant Clinical Professor in the Department of Public Health and Family Medicine at Tufts University School of Medicine in Boston, Massachusetts. She has held positions as Research Assistant and Project Coordinator at the Oregon Center for Applied Science (Eugene, Oregon) and as Associate Director of Research at HealthMedia (Ann Arbor, Michigan) where she worked with industry and health organizations to develop and evaluate e-health communication projects. She earned her PhD in Health Studies from Texas Woman s University and a post-doctoral fellowship in the Department of Clinical Epidemiology and Biostatistics, Evidence-Based Practice Centre, at McMaster University in Ontario Canada. Prof. Suggs is a co-founder of the European Social Marketing Association (ESMA) She is the Editor-in-Chief of the Journal of Communication Technology and Human Behaviors and is on the Editorial Board for the Journal of Health Communication: International Perspectives. 17

18 COURSE 4 (6 days) Methodology and Practical Application of Economic Evaluation and HTA in Health Care Prof. Bernard Burnand, Prof. Finn Børlum Kristensen, Prof. Mike Drummond, Marco Barbieri CONTENT OF THE COURSE Part 1 (Dr. Urs Brügger) The course is designed as a comprehensive introduction to the concepts, methods, and application of health technology assessment. Specific topics covered include: 1) Concepts: What is HTA? The multidisciplinary nature of HTA. HTA as a tool for decision making in health care. 2) Methods: An overview over HTA methods that are used to generate evidence on safety, effectiveness, costeffectiveness and other domains. How to deal with uncertainty. 3) Application: Using HTA in different contexts and jurisdictions for decision making, institutional settings (processes and structures) The link between policy and HTA. Examples and case studies are used to illustrate the main points Part 2 (Prof. Drummond, Marco Barbieri) The course is designed as an introduction to the concepts, methods, and application of economic evaluation in health care. Specific topics that will be covered include: an overview of economic evaluation methods, cost and benefit estimation, economic evaluation using patient-level data, economic evaluation using decision-analytic modelling, and using economic evaluation in healthcare decision-making. Numerous examples and case studies are used to illustrate the main points and considerable emphasis is placed on learning through and exercises. There will be ample opportunity for students to discuss any issues or problems they have already encountered in the field of economic evaluation. The course will be of particular benefit to those working in the health care sector who have a need to present a case for funding or reimbursement of particular health care treatments or programs. OBJECTIVES Part 1 By end of this course participants will be able to understand HTA, its methodology and its embeddedness in an institutional context (processes and organizational structures). Part 2 At the end of the course, the student will: be familiar with the concepts, methods and applications of economic evaluation in healthcare; understand costing methodology and the different approaches to valuing the benefits of health treatments; be able to undertake a critical appraisal of published studies; understand the limitations of clinical trials as a vehicle for economic evaluation; be familiar with decision-analytic modelling approaches, including the construction of decision trees and Markov models; appreciate the main issues in the use of economic evaluation in health care resource allocation decisions, including the reimbursement of health technologies; have an appreciation of future developments in the theory and application of economic evaluation in health care. PREREQUISITES The course is intended for graduate students who have a background in public management, economics, or the health disciplines. No previous knowledge of HTA is assumed. The course is intended for graduate students (or equivalent) who have a background in economics, or the health disciplines. Some previous knowledge of economic evaluation is desirable, although this can be acquired through the pre-reading that is offered with this course. Some work experience in the health care sector is desirable, but not essential. 18

19 COURSE 4 (6 days) PEDAGOGICAL METHOD Lectures, interactive exercises, group s. ASSESSMENT PROCEDURE Part 2: Written examination DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday Introduction to HTA Lecture, group Monday (Scientific) evidence and decision making Case studies I Tuesday HTA in different contexts (Standard processes and Managed entry schemes) Lecture, group s Tuesday Case studies II Wednesday Integrating economic evaluation into health technology assessment Introduction to economic evaluation Key principles of using HTA in resource allocation decisions Lectures plus Wednesday Costing, including costing exercise Discounting in economic evaluation Lectures, and Thursday Measuring benefits in economic evaluation Lectures, and Thursday Economic evaluation alongside clinical studies Lectures, and Utility estimation exercise Economic evaluation and social values Handling uncertainty Feedback on the utility exercise Friday Decision- analytic modelling Modelling exercise Lectures, and Friday Modelling exercise (continued) Transferring economic evaluations from one country to another Lectures, and Saturday Critical appraisal of economic evaluations Exercise on critiquing a published study Lectures, and Saturday Using economic evaluations in making resource allocation decisions Course assessment Lecture Written examination 19

20 COURSE 4 (6 days) CURRICULUM VITAE Urs Brügger is a health economist and the director of the Winterthur Institute of Health (WIG) at the Zurich University of Applied Sciences in Winterthur (ZHAW), Switzerland. His fields of interest in research and teaching are Health Technology Assessmen (HTA), Patient Classification Systems (PCS) and Managed Care. He is a board member of the Swiss Network for Health Technology Assessment and since July 2013 of the Swiss Academy of Medical Sciences (SAMS). He studied at the University of St. Gallen (HSG) economics and sociology (1990). He has a PhD in from the University of St. Gallen (1999). In the year 2009 he received a MSc in HTA (Ulysses program). Dr. Mike Drummond is Professor of Health and former Director of the Centre for Health at the University of York. His particular field of interest is in the economic evaluation of health care treatments and programmes. He has undertaken evaluations in a wide range of medical fields including care of the elderly, neonatal intensive care, immunization programmes, services for people with AIDS, eye health care and pharmaceuticals. He is the author of two major textbooks and more than 600 scientific papers, has acted as a consultant to the World Health Organization and was Project Leader of a European Union Project on the Methodology of Economic Appraisal of Health Technology. He has been President of the International Society of Technology Assessment in Health Care, and the International Society for Pharmacoeconomics and Outcomes Research. He was previously a member of the Guidelines Review Panels of the National Institute for Health and Clinical Excellence (NICE) in the UK, and is a Principal Consultant for OptumInsight. His most important publications are: Drummond, M.F., Sculpher, M.J., Torrance, G.W., O Brien, B.J., Stoddart, G.L. (2005), Methods for the economic evaluation of health care programmes: third edition. Oxford, Oxford Medical Publications. Drummond, M.F., Barbieri, M., Wong, J.B. (2005), Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference? Medical Decision Making; 25(5): Drummond, M.F.,Schwartz, J.S., Jönsson, B., Luce, B.R., Neumann, P.J. (2008) Key principles for the improved conduct of health technology assessments for resource allocation decisions. International Journal of Technology Assessment in Health Care; 24(3): Marco Barbieri, M.Sc. is an Honorary Research Fellow at the Centre for Health, University of York (UK) and a Associate Researcher of CRES ( and Health Research Centre), University Pompeu Fabra, Barcelona (Spain). He holds a B.Sc. in from the University of Bologna (Italy) and an M.Sc. in Health from the University of York (UK). He spent two years working as a Research Fellow at the Centre for Health, University of York, where he has undertaken a wide range of research including cost-effectiveness modelling in rheumatoid arthritis and cardiovascular disease, study of patient preference measurement and the application of evidence to decision making in health care. He has been involved in several health technology assessments, including systematic reviews of economic evaluations of treatments for bipolar disorder and for second-line advanced ovarian cancer. His particular field of interest is associated with issues of transferability of data among jurisdictions. Barbieri M, Drummond M, Rutten F et al. What do international guidelines say about economic data transferability, Value in Health 2010, 13 (8): Barbieri M, Hawkins N, Sculpher M et al. Who Does the Numbers? The Role of Independent Technology Assessment to Inform Health Systems Decision Making about the Funding of Health Technologies, Value in Health 2009; 12(2): Barbieri M, Drummond MF, Willke R, Chancellor J, Jolain B, Towse A. Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability, Value in Health 2005, Vol 8 (1),

21 COURSE 5 (6 days) Leadership and Communication Prof. François Lagarde CONTENT OF THE COURSE Leadership Communication Health Communication Key health communication principles Risk communication Planning, delivering and evaluating health communication initiatives: overall objectives, audience analysis, context, outcome objectives, framing/positioning, channels and activities, message development, messengers, partnerships, implementation, evaluation Communicating to inform and influence individual decisions and behaviours Communicating with staff and colleagues (internal communications) Communicating with professionals and stakeholders (knowledge transfer) Communicating with policy makers (advocacy) Communicating with the media OBJECTIVES By the end of this course, participants will: Have acquired a broad understanding of health communication principles, methods, and practices to achieve a range of health management and public health objectives Know best practices in health communication Be able to apply best practices to a range of initiatives aimed at individuals, staff, professionals, stakeholders, policy makers and the media. PREREQUISITES None. PEDAGOGICAL METHOD Lectures, reading, s, case studies, small, group presentations. ASSESSMENT PROCEDURE Participants are expected to attend each session (30%) Group presentation of a case study (15 min, including a PowerPoint presentation) and (15-20 min) on last day (70%). 21

22 COURSE 5 (6 days) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday Introduction Definitions and principles Lecture Discussions Monday Risk communication Planning and evaluating health communication initiatives Lecture Discussions Channels and message development Tuesday Communicating to change individual behaviours Lecture Discussions Tuesday Social marketing; links between communication and comprehensive approaches Case study and application Lecture Small group work Wednesday Short group presentations on key elements of a strategy to influence individual behaviours Group presentations Discussions Wednesday Communicating with staff and colleagues Case study and application Lecture Small group work Thursday Communicating with professionals and stakeholders (knowledge transfer) Lecture Thursday Case study and application Small group work Friday Communicating with policy makers (advocacy) Case study and application Lecture Small group work Friday Multimedia and communicating with the media Lecture Discussions Saturday Preparation for a group presentation on a communication strategy Small group work Saturday Group presentations of a strategy Group presentations and s 22

23 COURSE 5 (6 days) CURRICULUM VITAE Prof. François Lagarde François Lagarde, M.A., has held the position of Vice-President, Communications at the Lucie and André Chagnon Foundation since June He is responsible for orienting, managing and ensuring the synergy of all communication strategies used by the Foundation in connection with its philanthropic investments. He also advises the President and other members of the Executive on public affairs and other strategic issues. Since serving as Vice-President of ParticipACTION (a national health promotion agency) in the 1980s, he has acted as a consultant in social marketing and communications for more than 170 health, community, public and philanthropic organizations at every level. Through his work, he has contributed to the design, implementation and evaluation of many social and behavioural change initiatives. François Lagarde is also an adjunct professor at the University of Montreal, where he teaches social marketing in the health administration and public health programs. He received the University of Montreal Award for Excellence in Teaching. He has built up a solid reputation both nationally and internationally. As a sought-after speaker and trainer, he has taught in all the Canadian provinces as well as in 12 other countries. Mr. Lagarde is an Associate Editor of Social Marketing Quarterly. 23

24 COURSE 6 (3 days August) Health Financing Policies, Health System Performance and Obstacles to Universal Health Coverage Dr. David B Evans Dr. Fabrizio Tediosi CONTENT OF THE COURSE The course provides students with an overview of the patterns and key issues of health systems financing policies, with an emphasis on critical assessment of current and future policy options and issues. The course analyses methods and tools to assess health financing policies and it reviews effective policy instruments to improve health system performance through better health financing policy. It is structured around the following topics: Objectives of health financing system; Raising revenues thinking outside the box; Pooling revenues insurance, taxes and the costs of fragmentation; Purchasing getting more health for the money including questions of benefits packages; Health system development that complements health financing reforms; Coordinating reform aligning policy instruments with policy objectives. The course offers examples and practical experiences from low, middle, and high income countries. The key principles and challenges of attaining and maintaining universal coverage, as well as the tools analysed, are relevant to low, middle and high income countries. OBJECTIVES At the end of the course participants will be: Familiar with the key issues in health systems financing for ensuring access to needed services with financial risk protection; Able to assess alternative methods of: raising revenue to funding health services; pooling funds to spread financial risks and reduce financial barriers to access; and purchasing or providing services efficiently and effectively; Able to appreciate the challenges of health systems and financing policies that can benefit the poor; Able to identify some of the other types of health system strategies that are needed to support changes in health financing policies; Able to adopt a systematic approach to assess and design health financing policies PREREQUISITES No specific prerequisite. The course will mostly benefit policy-makers and practitioners at all level of seniority in the health sector, managers of service-provider organizations and individuals involved in health system reforms. It will benefit also individuals interested in how health systems can address existing inequalities in access to health services, in how the global health community can support national health systems to develop and implement financing policies. PEDAGOGICAL METHOD Introductory lectures, case studies, facilitated and. ASSESSMENT PROCEDURE Group work presentation underlined by a short synthesis text (2 pages). 24

25 COURSE 6 (3 days August) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday 11.00am 1pm Challenges of health financing systems to attain and maintain Universal Health Coverage Lecture and group Monday Health financing policies in low, middle, and high income countries Facilitated and Tuesday 11.00am 1pm Policy instruments to improve health system performance through better health financing policy Lecture and group Tuesday Health systems strategies supporting health financing policies Facilitated and Wednesday 11.00am 1pm Methodologies to assess health financing policies Lecture and group Wednesday 2pm 4.30pm Group work presentations of case studies assigned by facilitators Group presentations and 25

26 COURSE 6 (3 days August) CURRICULUM VITAE David B. Evans is Director of the Department of Health Systems Governance and Financing in the Cluster on Health Systems and Services at the World Health Organization. He has a PhD in economics and worked as an academic in Australia and Singapore before joining WHO. His work has covered social and economic aspects of tropical disease control, the assessment of health system performance and the generation, analysis and application of evidence for health policy. His current focus is on supporting countries to develop effective, efficient and equitable health financing systems, and to strengthen leadership and governance within health systems. Activities range from technical support to countries, generation and use of evidence on best practices, sharing of country experiences, capacity strengthening and partnership with other development agencies and initiatives. He was the lead author for the World Health Report 2010 entitled Health systems financing: the path to universal coverage and has over 200 publications. Fabrizio Tediosi is Group Leader for Health Policy in the Health Systems Research and Dynamic Modeling Unit of the Swiss Tropical and Public Health Institute, University of Basel. Since 2007 he is also associate researcherat the Centre for Research on Health and Social Care Management of Bocconi University in Milan. He holds a degree in economics and management from the University of Pavia, an MSc in Health from the University of York, and a PhD in Public Health and Epidemiology from University of Basel. 26

27 COURSE 7a (3 days August) Incentives for Better Health Prof. Iris Bohnet Prof. Nikola Biller-Andorno Dr. Divya Srivastava CONTENT OF THE COURSE The course is designed as a comprehensive introduction to the role of incentives in redesigning care for better quality at lower cost. The course will engage participants in specific issues including conceptual issues, the effectiveness of different forms of incentive schemes, such as pay for performance as well as ethical and policy issues. The course is intended for graduate students, post-docs or practitioners with background in health care, public health, management, economics or ethics. Some previous knowledge of incentives as a management tool is desirable, although this can be acquired through the pre-reading that is offered with this course. OBJECTIVES At the end of the module students will: Have an understanding of incentives grounded in the recent literature in behavioural economics, ethics, and other relevant fields Appreciate the role of incentives in health behaviour, as well as health care design, management and delivery Be able to analyze pitfalls of incentive designs and to critically reflect on incentives as a potential source of institutional corruption Be familiar with framework conditions for an ethically responsible use of incentives Be able to identify indicators needed to manage incentives and performance evaluation as a learning systems PREREQUISITES The course is intended for doctoral students and professionals who have a background in health care management, public health, ethics, economics, or the health disciplines. Some previous knowledge of incentives as a management tool is desirable, although this can be acquired through the pre-reading that is offered with this course. Some work experience in the health care sector is desirable, but not essential. PEDAGOGICAL METHOD The course will be held using lectures, interactive exercises, facilitated group s, and breakout sessions. ASSESSMENT PROCEDURE Group presentation (15 min) and (15-20 min). 27

28 COURSE 7a (3 days August) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday 11.00am 1pm Introduction to the use of incentives from the behavioural economics perspective Lecture by Prof. Iris Bohnet (Harvard) Monday Examining the use of incentives and their implications from the behavioural economics perspective Group s and activities led by Iris Bohnet Tuesday 11.00am 1pm Practical examination of the current uses of incentives in health care Lecture by Divya Srivastava (OECD) Tuesday Exploring and comparing the use of incentives in health care Group s and activities led by Divya Srivastava Wednesday 11.00am 1pm Examination of the ethical considerations of using incentives to improve health system performance Lecture by Prof. Nikola Biller-Andorno (University of Zurich) Wednesday Applying ethical considerations to policies that use incentives to improve health system performance Group s and activities led by Prof. Nikola Biller-Andorno CURRICULUM VITAE Iris Bohnet, Professor of Public Policy, is the Academic Dean of the Harvard Kennedy School. A behavioral economist, she is also the director of the Women and Public Policy Program, an associate director of the Harvard Decision Science Laboratory, and the faculty chair of the executive program Global Leadership and Public Policy for the 21st Century for the World Economic Forum s Young Global Leaders. She serves on the boards of directors of Credit Suisse and University of Lucerne, as well as the Advisory Board of the Vienna University of and Business, and numerous academic journals. She is a member of the Global Agenda Council on Women s Empowerment of the World Economic Forum. Professor Bohnet teaches decision-making, negotiation and gender in public policy and leadership in degree and executive programs, and has been engaged in the teaching, training and consulting of private and public sector leaders in the United States, Europe, India and the Middle East. Prof. Dr. med. Dr. phil. Nikola Biller-Andorno directs the Institute of Biomedical Ethics of the University of Zurich, Switzerland ( a WHO Collaborating Centre for Bioethics, as well as the PhD program Biomedical Ethics and Law (medical track) ( She has acted as deputy editor of the Journal of Medical Ethics from 2004 to 2011, and is Past-President of the International Association of Bioethics. She is a member of the Central Ethics Committee of the Swiss Academy of Medical Sciences, Vice-President of the Clinical Ethics Committee of the University Hospital Zurich, and a member of the Research Ethics Committee of the Federal Institute of Technology Zurich. In , she was a Commonwealth Fund Harkness Fellow and Visiting Professor of Biomedical Ethics at Harvard University. Dr. Divya Srivastava is a health economist at the Organisation for Economic Cooperation and Development (OECD) in Paris. She is involved in projects relating to value for money which include investigating medical practice variations and payment systems across OECD countries. She is also a visiting fellow at the London School of and Political Science (LSE) and an associate editor of the journal Globalization and Health, an open access online journal. Divya has also worked for the World Health Organization European Observatory on Health Systems and Policies, the UK Government, the Canadian government and as a consultant to the UK government and Australian government. She holds a B.Sc in Statistics from the University of Manitoba (Canada), a M.A. in from McMaster University (Canada), MSc. in International Health Policy from the LSE and a PhD from the LSE. Research interests include comparative health policy, health economics and pharmaceutical policy. 28

29 COURSE 8a (3 days August) Rationales in Public Health Decisions How to Handle Research Information to Improve Decision-making Dr. André Prost Dr. Roberto Grilli CONTENT OF THE COURSE Participants will know the factors to be considered to become critical users of research information, and the steps to be undertaken to move from a public health problem/issue to a decision, through a careful appraisal of alternative options and implications relying on research information. OBJECTIVES To make participants familiar with the potentials as well as with the limitations and problems of relying on information drawn from health research in the decision making process on public health issues. In particular participants will learn how to interpret and critically appraise systematic reviews, practice guidelines, health technology assessment reports and other forms of research synthesis exercises. In addition, they will have the opportunity to explore how to draw researchable questions from health policy issues. PREREQUISITES None. PEDAGOGICAL METHOD The module will be based on traditional frontal lessons and more interactive sessions in which case studies will be examined, applying to real life examples theories, concepts and methods introduced in the lectures. ASSESSMENT PROCEDURE A practical exercise will be conducted at the end of the module, in which participants will be asked to apply concepts and methods learned to an health policy issue/problem. 29

30 COURSE 8a (3 days August) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Monday How can/should research influence policy-making (part I: methodological aspects and role of indicators) André Prost How can/ should research influence policy-making (part I: methodological aspects and role of indicators) André Prost Monday From problems to solutions through research information - Case Study I: the Management of waiting list Roberto Grilli Interactive group working Tuesday 10am 1pm How can/should research influence policy-making (part II: the value and limitations of research synthesis exercises) Roberto Grilli How can/ should research influence policy-making (part II: the value and limitations of research synthesis exercises) Roberto Grilli Tuesday From problems to solutions through research information - Case study II: The Relationship between volumes and outcomes Roberto Grilli Interactive group working Wednesday 11 am 1pm The other way round: how policy can influence research Roberto Grilli The other way round: how policy can influence research Roberto Grilli Wednesday From problems to solutions through research information - Case study III: Breast cancer screening André Prost Interactive group working 30

31 COURSE 8a (3 days August) CURRICULUM VITAE André Prost Former Director at the WHO, Geneva, in charge of Relationships with Governments and the Private Sector, Dr André Prost was between 2007 and 2013 a member of the Board of Governors of the GAVI Fund Affiliate which finances part of the operations of the Global Alliance for Vaccines and Immunization in the 73 least developed countries. Dr Prost, MD, is a specialist in parasitology with a degree in epidemiology from Institut Pasteur, Paris. During twelve years, 1969 to 1981, he worked in West Africa, first as a district medical officer in Upper Volta (present Burkina Faso), then as responsible for the epidemiological evaluation of the Onchocerciasis Control Programme in West Africa. Within WHO, he held the following positions: epidemiologist, Division of the Environment ( ); assistant to the Deputy Director-General ( ); Representative to the European Union and its Member States in Brussels ( ); Director non-communicable diseases ( ); Director, Relationships with Governments and the Private sector ( ). Within the World Bank in Washington ( ), Dr Prost worked as a Public Health officer in the Population, Health and Nutrition department, responsible for projects in China, Thailand and Ghana. The early stages of his career were totally field oriented as a resident in hospitals in Morocco ( ), as a district medical officer in rural areas of Upper Volta ( ) and as team leader for the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin, West Africa. Teaching functions have included a collaboration with the Master of Epidemiology of Paris VI University ( ), with the master of Advanced Studies in Public Health of Geneva University ( ), with the international course on Public Health Ophthalmology in Rabat, Morocco ( ), to quote only the most important ones. He was a member of the scientific committee of the Universita della Pace Giorgio La Pira, Torino ( ). Dr Prost was also a member of the National Committee for the Coordination of Resarch for Development at the French Ministry of Resarch (1995), and a Member of the Steering Committee for the qualitative health planning of the Canton of Geneva ( ) Dr Prost is the main author or the co-author of over one hundred scientific papers. Dr Prost is President of the Scientific advisory Board of the Press Agency Destination Santé. Entomologist, he is the current Secretary of the International Association of Neuropterology. Roberto Grilli, epidemiologist and health services researcher, since 2006 is the Director of the Regional Agency for Health and Social Care of Emilia-Romagna, the organization supporting the Regional Health Authority of Emilia-Romagna (a 4,5-million resident Italian region) in the development, adoption, and evaluation of clinical, organizational and technological innovations in the regional health and social care system. From December 2000 to June 2006 he was head the Department of Clinical Governance (Area di Programma Governo Clinico) at the same institution. Previously Dr Grilli was, from 1986 to 1998, at the Mario Negri Institute in Milan, Italy, where he held the position of Head of the Unit of Clinical Policy Analysis, within the Laboratory of Health Services Research. From August 1991 to September 1992 he was visiting assistant professor at the Centre for Health and Policy Analysis (McMaster University, Hamilton, Ontario). From January 1999 to October 2000 he has been senior executive at the National Agency for Regional Health Services (Agenzia per i Servizi Sanitari Regionali), where he was responsible for the organization of the Italian National Program for Guidelines Development and Implementation (Programma Nazionale per le Linee-Guida). He has been working extensively in the area of health technology assessment, quality assessment of the scientific literature, quality of care evaluation, development and implementation of practice guidelines, governance in healthcare organizations. He has been involved in several national and international projects, being also (from 1994 up to 2006) among the members of the editorial team of the Cochrane Effective Practice and Organization of Care (EPOC) Review Group. He is author and co-author of 186 scientific publications, and of three books. 31

32 COURSE 7b (3 days August) Conflicts of Interest and Corruption from a Health Systems Perspective Prof. Marc Rodwin, Prof. David Klemperer, Prof. Olivier Guillod, Prof. Nikola Biller-Andorno, Lida Lhotska and Dr. Judith Richter CONTENT OF THE COURSE Presentation of theories on conflict of interest in medicine, different national responses and global initiatives with of case studies OBJECTIVES To enable health professionals and policy makers to better identify financial conflicts of interest and to participate in the development of ways to address them at the individual and societal level. PREREQUISITES The course is intended for doctoral students and professionals who have a background in health care management, public health, ethics, economics, or the health disciplines. Some work experience in the health care sector is desirable, but not required. PEDAGOGICAL METHOD The course will use lectures, interactive exercises, facilitated group s, and student presentations. ASSESSMENT PROCEDURE Student presentations (15 min) and (15-20 min) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Thursday Exploring conflicts of interest and institutional corruption of medical systems from a legal perspective. Lecture by Prof. Marc Rodwin (Suffolk University/ Harvard) Thursday Exploring conflicts of interest and institutional corruption in health care building on the findings from a comparative study on conflict of interest in the US, French and Japanese health care system. Joint exploration of ways to address conflicts of interests and bribing in the participants health care settings. Group s and activities led Marc Rodwin Friday Investigating conflicts of interests in health care settings and the role health professionals can play to address the problems Conflicts of interest in the global health arena and the role of international organizations Lecture by Prof. David Klemperer (Hochschule Regensburg) Friday Group s and activities led David Klemperer Saturday Lecture by Dr. Judith Richter with case study by Dr. Lhotska Saturday Discussion of conflicts of interest in the global health arena: how to ensure that health policy making is in the public interest? Group s and activities led by Judith Richter, Lida Lhotska nad Nikola Biller-Andorno 32

33 COURSE 7b (3 days August) CURRICULUM VITAE Marc A. Rodwin is Professor of Law at Suffolk University Law School and a Lab Fellow at the Edmond J. Safra Center for Ethics at Harvard University. He is the author of Conflicts of Interest and the Future of Medicine: The United States, France and Japan (Oxford, 2011); and Medicine, Money & Morals: Physicians Conflicts of Interest (Oxford, 1993). He has written on ownership of data, physicians conflicts of interests, competition law, and managed care, the pharmaceutical industry, medical malpractice, health economics, and patient rights. Rodwin has testified before Congress and state legislatures and served on government commissions and advisory boards. He has participated in meetings of the National Academy of Sciences, Institute of Medicine. Rodwin has assisted consumer groups including the Consumer Federation of America, the National Partnership for Women and Families, and Consumer Coalition for Quality Health Care. Rodwin has been a recipient of several fellowships and grants including: Fulbright Fellowship, German Marshal Fund, Social Science Research Council/Abe Fellowship; Robert Wood Johnson Foundation Investigator Award, and the Pew Health Policy Doctoral Fellowship. Prof. Dr. med. Dr. phil. Nikola Biller-Andorno directs the Institute of Biomedical Ethics of the University of Zurich, Switzerland ( a WHO Collaborating Centre for Bioethics, as well as the PhD program Biomedical Ethics and Law (medical track) ( She has acted as deputy editor of the Journal of Medical Ethics from 2004 to 2011, and is Past-President of the International Association of Bioethics. She is a member of the Central Ethics Committee of the Swiss Academy of Medical Sciences, Vice-President of the Clinical Ethics Committee of the University Hospital Zurich, and a member of the Research Ethics Committee of the Federal Institute of Technology Zurich. In , she was a Commonwealth Fund Harkness Fellow and Visiting Professor of Biomedical Ethics at Harvard University. Born on April 20, 1956 in Neuchâtel (Switzerland), Olivier Guillod studied law at the Universities of Neuchâtel and Harvard (USA) and practiced as a barrister in the eighties. He taught private law and health law at the Universities of Geneva and Webster and then at the University of Neuchâtel, where he founded the Institute of Health Law in 1993 and served as Dean of the Law School. He has been invited to teach in several Swiss (Fribourg, Lausanne, Genève), French (Paris V, Aix-Marseille) and New Zealand (Otago) Universities. He was a member of the Swiss National Advisory Committee for Biomedical Ethics ( ) and chaired the Cantonal Committee on Addictions (Neuchâtel). He is Dr. Hon. causa of the University of Franche-Comté and has been an individual member of the Swiss Academy of Medical Sciences since Olivier Guillod has given numerous talks in Switzerland and abroad, has served as a member of the editorial board of several scientific Journals, especially the Swiss Review of Health Law, and has written extensively on health law topics. He is presently director of the Institute of Health law and professor of private law and health law at the University of Neuchâtel David Klemperer, MD, is Professor of Social Medicine and Public Health at the Faculty of Social and Health Sciences, Ostbayerische Technische Hochschule Regensburg. His research and teaching focus on evidencebased professional practice and conflicts of interest. He is co-author of a the recommendations oft the Association of the Scientific Medical Societies (AWMF) on regulating conflicts of interest in medical speciaist societies ( and co-editor of a German textbook Interessenkonflikte in der Medizin. He is past president of the German Network for Evidence-based Medicine ( Website: 33

34 COURSE 7b (3 days August) Lida Lhotska, BSc in Biology and PhD in physical anthropology, worked for eleven years at the National Institute for Public Health in Prague, where she was one of the coordinators of the nation-wide anthropological surveys of children and adolescents and coordinator of the field-team of a USAID funded Project on Reduction of Cardiovascular and Cerebrovascular Diseases in Czech Republic. She also taught infant feeding and clinical anthropology at one of Prague s Medical Schools. After the political changes in 1990, she co-founded the first national group of the International Baby Food Action Network (IBFAN) in the Central & Eastern European region. In 1994, Dr. Lhotska joined the nutrition team at UNICEF headquarters in New York where she was responsible for Infant Feeding and Care. This involved direct support to country programmes and coordination with government counterparts, NGOs and donors. In 2001 she took the position of IBFAN Regional Coordinator for Europe (more than 50 national groups) at the IBFAN-GIFA Office in Geneva. She is also responsible for liaisons with international organisation and NGOs, policy guidance and technical support on infant feeding issues. In both her UN and NGO capacity, she has carried out numerous missions in developing and industrialised countries. She has followed the increase of conflicts of interest in the global health and nutrition arena with concern. Since the late 1990s, she has been trying to raise awareness of their problematic impacts, including decreasing spaces for holding corporations accountable for their harmful marketing practices and human rights violations. Judith Richter has recently joined the Institute of Biomedical Ethics at the University of Zurich as Associate Senior Research Fellow. Her multi-disciplinary background combines knowledge of the humanities with health sciences (PhD Social Sciences; Ethics in the Sciences and Humanities; MA in Development Studies; MSc Pharmaceutical Sciences). Throughout her professional career, Judith Richter has interwoven her work as a freelance researcher and consultant for UN agencies, governments, academic institutes, civil society organisations and networks with her work as a pharmacist. In the 1980s, she gained first hand insight into the challenges of consumer protection in developing countries during her four years in Thailand, first as a lecturer of community pharmacy at Khon Kaen University, then as an international information coordinator of the Bangkok-based Drug Information Action Centre (DIAC). She has been working as a researcher for civic engagement and has given presentations and organised workshops in numerous countries around the world ever since. Her key areas of research and writing in the field of democratic health governance are: safeguards for public interests in UN-business relationships, global public-private partnerships & multi-stakeholder alliances; accountability of transnational corporations; and corporate public relations in reaction to regulatory efforts. Courserelevant publications include: WHO reform and public interest safeguards: An historical perspective, Editorial. Social Medicine (2012); Global partnerships and Health for All: Towards an institutional strategy. Discussion paper prepared for WHO s Department of Government, Civil Society and Private Sector Relations (GPR), Geneva (2005); Public-private partnerships and international health policy-making: How can public interests be safeguarded? Elements for Discussion Series, Ministry for Foreign Affairs, Finland (2004); Conflicts of interest and policy implementation: Reflections from the field of health and infant feeding. IBFAN-GIFA, Geneva (2005); Codes in context: TNC regulation in an era of dialogues and partnerships. Briefing Paper, The Corner House (2001); Holding corporations accountable: Corporate conduct, international codes, and citizen action. Zed Books (2001) 34

35 COURSE 8b (3 days August) Bridging the Gap between Evidence and Policy Making Prof. Andrew Street CONTENT OF THE COURSE Setting priorities: Who should have priority for treatment? What treatments should have priority? Introduces concepts of: Priority setting; Efficiency-equity trade-offs Evaluating hospital performance. Is there a trade-off between costs and quality? Introduces concepts of: QALYs, Patient reported outcomes, EQ5D; Econometric models; Risk adjustment; Evaluation of hospital performance across multiple dimensions Can primary care physicians reduce the use of hospital care? Introduces concepts of: Gatekeeping, primary-secondary interface; Fundholding and budget-holding; Team working; Evaluation over time and space: difference-in-difference analysis Productivity measurement: What is the impact of policy on health system productivity? Introduces concepts of: National accounts; Measurement of health care output, input and productivity an national level; Productivity growth over time; Relationship between expenditure, prices and inputs; Sub-national productivity analysis: by geographical area or hospital Comparing health system performance: Who has the best health system? Introduces concepts of: International comparisons;who measurement of health performance; Commonwealth Fund evaluation of performance; Econometric, panel data and stochastic frontier analysis; FIFA s league table of national football teams OBJECTIVES This course is designed to provide insight into: (i) the nature of policy challenges, including trade-offs and the need for priorisation; (ii) to how evidence can inform policy design; (iii) the challenges involved in evaluating policy implementation and analytical approaches to meeting these challenges; (iv) examples of policy evaluations and performance measurement drawn from primary care and hospital care, and of national and international comparisons PREREQUISITES Basic understanding of economics and statistics would be helpful but not essential. PEDAGOGICAL METHOD Mixture of lectures,, individual and group paper exercises. Computer based exercises conditional on available facilities ASSESSMENT PROCEDURE Over the course of the three-day intensive class, students will demonstrate obtainment of learning objectives through class s and the final session. The final session will culminate in a summary report highlighting lessons learned. 35

36 COURSE 8b (3 days August) COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Thursday Setting priorities: Who should have priority for treatment? What treatments should have priority? Lecture and ice-breaker exercises, allowing individual and Lecture and Thursday Lecture: Evaluating hospital performance. Is there a trade-off between costs and quality? Group work Group work Lecture and Friday Lecture: can primary care physicians reduce the use of hospital care? Friday Group work Saturday Lecture: productivity measurement: What is the impact of policy on health system productivity? Lecture and Saturday Group work Lecture: Comparing health system performance: Who has the best health system? Group work and lecture CURRICULUM VITAE Andrew Street is a Professor of Health, Director of the Health Policy team in the Centre for Health and Director of the of Social and Health Care Research Unit, a joint collaboration between the Universities of York, Kent and London School of. He is an editor of the Journal of Health, an external affiliate to the Department of Business and at the University of Southern Denmark and currently serves as a board member on the NIHR Health Services and Delivery Research programme Commissioning Board (since 2009) and the Norwegian HSR Board (since 2011), and as chair of the Welsh Health Support Service Advisory Group. Andrew s research covers measurement of health system productivity, evaluation of activity based funding mechanisms, analysis of organisational efficiency, and critical appraisal of health policy. He has a MSc in Health (1990), a MA in Public Administration and Public Policy (2000) and a PhD in (2002), all awarded by the University of York. After completing his MSc, Andrew spent three years in Australia working at the National Centre for Health Program Evaluation, Monash University and the Victorian Department of Health and Community Services. This was followed by a five-year spell with the York Health Consortium. He joined the Centre for Health in April From he held a special training fellowship awarded by the Medical Research Council and Northern and Yorkshire Region. In 2005 he worked part time in the Delivery Analytical Team in the English Department of Health. 36

37 COURSE 9 (3 days August) Non-communicable Disease Control: Public Health and Health Care Approaches Prof. Kaspar Wyss Prof. Pascal Bovet CONTENT OF THE COURSE The course addresses public health strategies to curb non-communicable diseases (NCD), and changes needed in the health care system, particularly with regards to those most effective, affordable and scalable ( best buys ) interventions. The respective contributions of the priority multisectoral public health approaches versus the main changes needed within the health care system are identified and discussed. The focus is on discussing, exposing and contrasting the respective contributions of a public health (relying on non-health actors, targeting the healthy population) and a health care system (health care actors, patients) approaches to NCD prevention and control. OBJECTIVES The participants should at the end of the course to: Know effective, efficient, equitable and sustainable approaches for NCD prevention and control in middleand low-income countries. Be aware of the most cost-effective and affordable public health interventions and key ( best buys ) for the prevention and control of NCDs and relate them to health systems strengthening. Be aware of the most critical elements needed to strengthen health care services for the delivery of cost effective management of non-communicable diseases. Identify the rationale, benefits and resources needed for implementing, respectively, the public health approach versus the health services approach for the prevention and control of NCDs. PREREQUISITES Basic knowledge and experience in a medical or public health field. Interest for prevention and control in NCD in low and middle income countries. The course can also be of interest to persons involved in development programs in low and middle income countries that have a health component. PEDAGOGICAL METHOD Introductory lectures on the NCD burden and impact Introductory lectures on the main approaches for prevention and control of NCDs Presentation of health policy options for NCD prevention and control from both the public health and health systems perspectives Group work on NCD prevention and control approaches ASSESSMENT PROCEDURE Group work presentation underlined by a short synthesis text (2 pages) developing a rational for public health or health service approach (or both).

38 COURSE 9 (3 days August) DETAILED COURSE CONTENT AND STRUCTURE Morning Content Method Afternoon Content Method Thursday NCD burden and impact Introductory lecture (Pascal Bovet) Thursday Public Health perspective to NCD prevention and control Introductory lecture (Pascal Bovet) followed by Introductory lecture (Kaspar Wyss) followed by Presentation of followed by plenary Friday Public Health perspective to NCD prevention and control (continuation of Monday) Introductory lecture (Pascal Bovet) followed by Introductory lecture (Kaspar Wyss) followed by Friday Health systems perspective to NCD prevention and control Saturday Health systems perspective to NCD prevention and control (continuation of Tuesday) Saturday Non-communicable disease control: Contrasting Public Health and Health Service Approaches CURRICULUM VITAE Pascal Bovet: Pascal Bovet, MD, MPH, is board certified (FMH) in both internal medicine and in public health. He is an associate professor in cardiovascular disease epidemiology at the Institute of Social and Preventive Medicine at the University Hospital of Lausanne. He has led a collaborative cardiovascular research and prevention program with the Ministry of Health of the Republic of Seychelles since 1988, including the development of comprehensive tobacco control legislation. He has been PI of several cardiovascular studies in Seychelles, Tanzania and Switzerland. He often participates as a technical adviser for the World Health Organization in relation to surveillance, tobacco control, CVD prevention, and the evaluation of national programs of prevention of non-communicable diseases. He serves as a faculty in several international courses on cardiovascular epidemiology and prevention. Kaspar Wyss: Kaspar Wyss, PhD, is a Public Health Specialist, Associate Professor and Deputy Head of Department at the Swiss Centre for International Health, Swiss Tropical and Public Health Institute. Kaspar Wyss has strong management and leadership experience and is in charge of a team of 15 staff focusing on health systems development primarily in low- and middle income countries. Activities relate to both research and health system monitoring and performance assessment. He directs a number of research and implementation projects in Africa, Eastern Europe, and Asia and has extensive consultancy experiences for a broad range of clients. For the University of Basel (MSc and medical students) and for other courses including the Swiss Inter-University Master of Public Health Program he teaches on health systems. Kaspar Wyss acts further as supervisor for several PhD and MSc students.

39

40